AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 23 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,198,000 | +11.0% | 25,780,000 | -1.5% | 0.21% | -1.9% |
| Q2 2020 | $20,903,000 | +3.4% | 26,180,000 | 0.0% | 0.21% | -28.3% |
| Q1 2020 | $20,208,000 | -16.4% | 26,180,000 | -8.7% | 0.29% | +4.3% |
| Q4 2019 | $24,182,000 | +3.0% | 28,680,000 | 0.0% | 0.28% | -5.7% |
| Q3 2019 | $23,489,000 | +1.8% | 28,680,000 | 0.0% | 0.30% | -1.3% |
| Q2 2019 | $23,081,000 | -7.9% | 28,680,000 | 0.0% | 0.30% | -11.7% |
| Q1 2019 | $25,051,000 | -4.0% | 28,680,000 | 0.0% | 0.34% | +9.3% |
| Q4 2018 | $26,082,000 | -20.6% | 28,680,000 | -8.9% | 0.31% | -18.1% |
| Q3 2018 | $32,853,000 | +2.6% | 31,474,000 | +1.4% | 0.38% | -7.7% |
| Q2 2018 | $32,023,000 | +211.0% | 31,050,000 | +214.6% | 0.41% | +211.3% |
| Q1 2018 | $10,296,000 | -13.1% | 9,870,000 | -18.4% | 0.13% | +1.5% |
| Q3 2017 | $11,854,000 | -48.8% | 12,100,000 | -49.8% | 0.13% | -55.4% |
| Q2 2017 | $23,162,000 | – | 24,100,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|